Report Detail
Global Small Interfering RNA (siRNA) Therapeutics Market Size, Status and Forecast 2019-2025
- RnM3832201 |
- 13 November, 2019 |
- Global |
- 96 Pages |
- QYResearch |
- Other
This report focuses on the global Small Interfering RNA (siRNA) Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Small Interfering RNA (siRNA) Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
GE
Horizon Discovery
Thermo Scientific
OPKO Health
AInylam Pharmaceuticals
Arrowhead Research
Sanofi Genzyme
Genecon Biotechnologies
Arbutus Biopharma
Silent Therapeutics
Sylentis
Market segment by Type, the product can be split into
Liposome Based Systemic Therapy
Nanoparticle Based Systemic Therapy
Other
Market segment by Application, split into
Hospital
Research Institutions
Pharmaceutical and Biotechnology Companies
Academic Institutions
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Small Interfering RNA (siRNA) Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Small Interfering RNA (siRNA) Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Small Interfering RNA (siRNA) Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Liposome Based Systemic Therapy
- 1.4.3 Nanoparticle Based Systemic Therapy
- 1.4.4 Other
- 1.5 Market by Application
- 1.5.1 Global Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2019-2025)
- 1.5.2 Hospital
- 1.5.3 Research Institutions
- 1.5.4 Pharmaceutical and Biotechnology Companies
- 1.5.5 Academic Institutions
- 1.5.6 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Small Interfering RNA (siRNA) Therapeutics Market Size
- 2.2 Small Interfering RNA (siRNA) Therapeutics Growth Trends by Regions
- 2.2.1 Small Interfering RNA (siRNA) Therapeutics Market Size by Regions (2019-2025)
- 2.2.2 Small Interfering RNA (siRNA) Therapeutics Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
- 3.1 Small Interfering RNA (siRNA) Therapeutics Market Size by by Players
- 3.1.1 Global Small Interfering RNA (siRNA) Therapeutics Revenue by by Players (2014-2019)
- 3.1.2 Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by by Players (2014-2019)
- 3.1.3 Global Small Interfering RNA (siRNA) Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.2 Small Interfering RNA (siRNA) Therapeutics Key Players Head office and Area Served
- 3.3 Key Players Small Interfering RNA (siRNA) Therapeutics Product/Solution/Service
- 3.4 Date of Enter into Small Interfering RNA (siRNA) Therapeutics Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2014-2019)
- 4.2 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2014-2019)
5 North America
- 5.1 North America Small Interfering RNA (siRNA) Therapeutics Market Size (2014-2019)
- 5.2 Small Interfering RNA (siRNA) Therapeutics Key Players in North America
- 5.3 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Type
- 5.4 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Application
6 Europe
- 6.1 Europe Small Interfering RNA (siRNA) Therapeutics Market Size (2014-2019)
- 6.2 Small Interfering RNA (siRNA) Therapeutics Key Players in Europe
- 6.3 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type
- 6.4 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application
7 China
- 7.1 China Small Interfering RNA (siRNA) Therapeutics Market Size (2014-2019)
- 7.2 Small Interfering RNA (siRNA) Therapeutics Key Players in China
- 7.3 China Small Interfering RNA (siRNA) Therapeutics Market Size by Type
- 7.4 China Small Interfering RNA (siRNA) Therapeutics Market Size by Application
8 Japan
- 8.1 Japan Small Interfering RNA (siRNA) Therapeutics Market Size (2014-2019)
- 8.2 Small Interfering RNA (siRNA) Therapeutics Key Players in Japan
- 8.3 Japan Small Interfering RNA (siRNA) Therapeutics Market Size by Type
- 8.4 Japan Small Interfering RNA (siRNA) Therapeutics Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size (2014-2019)
- 9.2 Small Interfering RNA (siRNA) Therapeutics Key Players in Southeast Asia
- 9.3 Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size by Type
- 9.4 Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size by Application
10 India
- 10.1 India Small Interfering RNA (siRNA) Therapeutics Market Size (2014-2019)
- 10.2 Small Interfering RNA (siRNA) Therapeutics Key Players in India
- 10.3 India Small Interfering RNA (siRNA) Therapeutics Market Size by Type
- 10.4 India Small Interfering RNA (siRNA) Therapeutics Market Size by Application
11 Central & South America
- 11.1 Central & South America Small Interfering RNA (siRNA) Therapeutics Market Size (2014-2019)
- 11.2 Small Interfering RNA (siRNA) Therapeutics Key Players in Central & South America
- 11.3 Central & South America Small Interfering RNA (siRNA) Therapeutics Market Size by Type
- 11.4 Central & South America Small Interfering RNA (siRNA) Therapeutics Market Size by Application
12 International Players Profiles
- 12.1 GE
- 12.1.1 GE Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Small Interfering RNA (siRNA) Therapeutics Introduction
- 12.1.4 GE Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2014-2019))
- 12.1.5 GE Recent Development
- 12.2 Horizon Discovery
- 12.2.1 Horizon Discovery Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Small Interfering RNA (siRNA) Therapeutics Introduction
- 12.2.4 Horizon Discovery Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2014-2019)
- 12.2.5 Horizon Discovery Recent Development
- 12.3 Thermo Scientific
- 12.3.1 Thermo Scientific Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Small Interfering RNA (siRNA) Therapeutics Introduction
- 12.3.4 Thermo Scientific Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2014-2019)
- 12.3.5 Thermo Scientific Recent Development
- 12.4 OPKO Health
- 12.4.1 OPKO Health Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Small Interfering RNA (siRNA) Therapeutics Introduction
- 12.4.4 OPKO Health Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2014-2019)
- 12.4.5 OPKO Health Recent Development
- 12.5 AInylam Pharmaceuticals
- 12.5.1 AInylam Pharmaceuticals Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Small Interfering RNA (siRNA) Therapeutics Introduction
- 12.5.4 AInylam Pharmaceuticals Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2014-2019)
- 12.5.5 AInylam Pharmaceuticals Recent Development
- 12.6 Arrowhead Research
- 12.6.1 Arrowhead Research Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Small Interfering RNA (siRNA) Therapeutics Introduction
- 12.6.4 Arrowhead Research Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2014-2019)
- 12.6.5 Arrowhead Research Recent Development
- 12.7 Sanofi Genzyme
- 12.7.1 Sanofi Genzyme Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Small Interfering RNA (siRNA) Therapeutics Introduction
- 12.7.4 Sanofi Genzyme Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2014-2019)
- 12.7.5 Sanofi Genzyme Recent Development
- 12.8 Genecon Biotechnologies
- 12.8.1 Genecon Biotechnologies Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Small Interfering RNA (siRNA) Therapeutics Introduction
- 12.8.4 Genecon Biotechnologies Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2014-2019)
- 12.8.5 Genecon Biotechnologies Recent Development
- 12.9 Arbutus Biopharma
- 12.9.1 Arbutus Biopharma Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Small Interfering RNA (siRNA) Therapeutics Introduction
- 12.9.4 Arbutus Biopharma Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2014-2019)
- 12.9.5 Arbutus Biopharma Recent Development
- 12.10 Silent Therapeutics
- 12.10.1 Silent Therapeutics Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Small Interfering RNA (siRNA) Therapeutics Introduction
- 12.10.4 Silent Therapeutics Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2014-2019)
- 12.10.5 Silent Therapeutics Recent Development
- 12.11 Sylentis
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Product (2019-2025)
- 13.2 Market Size Forecast by Application (2019-2025)
- 13.3 Market Size Forecast by Regions
- 13.4 North America
- 13.5 Europe
- 13.6 China
- 13.7 Japan
- 13.8 Southeast Asia
- 13.9 India
- 13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 15.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Small Interfering RNA (siRNA) Therapeutics. Industry analysis & Market Report on Small Interfering RNA (siRNA) Therapeutics is a syndicated market report, published as Global Small Interfering RNA (siRNA) Therapeutics Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Small Interfering RNA (siRNA) Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
